Results 131 to 140 of about 6,767 (186)

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study. [PDF]

Front Oncol
Yuan Y, Tong Q, Liu JH, Kang Y.
europepmc   +1 more source

Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. [PDF]

Pediatr Blood Cancer
Harris EM, Montcrieff C, O'Farrell C, Konde P, Lambert MP, Grimes AB, Grace RF.   +6 more
europepmc   +1 more source

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag. [PDF]

Front Immunol
Sau A, Di Prinzio G, Onofrillo D, Russo AC, Santoro N, Di Ianni M.   +5 more
europepmc   +1 more source

GFI1B mutations define an emerging form of inherited thrombocytopenia: insights from a case report and literature review. [PDF]

Ann Hematol
Urbański B, Bąbol-Pokora K, Braun M, Janczar S, Michalak M, Sałacińska-Łoś E, Młynarski W, Treliński J.   +7 more
europepmc   +1 more source

Chemotherapy-induced thrombocytopenia: modern diagnosis and treatment. [PDF]

Br J Haematol
Song AB, Al-Samkari H.
europepmc   +1 more source

The Platelet-Virus Axis in Human Disease. [PDF]

Viruses
Siniscalchi C, Basaglia M, Imbalzano E, Di Micco P.   +3 more
europepmc   +1 more source

Acquired platelet disorders. [PDF]

Front Med (Lausanne)
Altahan RM.
europepmc   +1 more source

Portal vein thrombosis as a complication of Eltrombopag used in the treatment of immune thrombocytopenia in a patient of chronic liver disease.

Indian J Pharmacol
Kamath SD, Kumar M, Saha S, Sunder A.
europepmc   +1 more source

Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

BMJ
Chen Y, Xu Y, Dai J, Sun T, Li H, Hua Z, Zhou Z, Zhou H, Yan Z, Zhao X, Xue F, Liu W, Liu X, Fu R, Wang W, Chi Y, Dong H, Ju M, Dai X, Gu W, Pei X, Yang R, Zhang L.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New benzimidazoles as thrombopoietin receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2006
A novel benzimidazole series of small-molecule thrombopoietin receptor agonists has been discovered. Herein, we discuss the preliminary exploration of structure-activity relationships within this chemotype.
Richard M Keenan
exaly   +3 more sources